News

News
In the media

Mestag Therapeutics

Read full story
JNJ Press releases

LAVA THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS SECOND QUARTER RESULTS

Read full story
JNJ Press releases

New report reveals strength of the UK’s thriving genomics sector

Read full story
JNJ Press releases

MESTAG THERAPEUTICS EXTENDS SEED FINANCING TO $45 MILLION AND WELCOMES NEW INVESTORS FORBION, GV (FORMERLY GOOGLE VENTURES) AND NORTHPOND VENTURES

Read full story
Partner news

Apollo Therapeutics Completes $145 Million Financing Led by Patient Square Capital to Expand and Advance Portfolio-Based Drug Development

Read full story
Partner news

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Read full story
Partner news

Exonate announces the initiation of Phase Ib/II clinical trial for Diabetic Macular Oedema, as part of its collaboration with Janssen

Read full story
Partner news

£10 million research collaboration to detect lung cancer earlier

Read full story
Partner news

Revitope Oncology Announces Strategic Collaboration with Janssen to Leverage its Unique T Cell Engager Platform

Read full story
Partner news

Morphic Expands Research and Development Collaboration with Janssen Through Third Integrin Program

Read full story
Partner news

UK Biobank launches one of the largest scientific studies measuring circulating proteins, to better understand the link between genetics and human disease

Read full story
Other news

Big Data Institute announces collaboration with Janssen to advance understanding of human genetic signatures

Read full story
Partner news

Koa Health to collaborate with Janssen: Official press release

Read full story
Partner news

BaseLaunch announces that Johnson & Johnson Innovation has renewed its commitment becoming latest strategic partner in the second phase

Read full story
In the media

Inside Johnson & Johnson’s Nonstop Hunt for a Coronavirus Vaccine

Read full story